Q-omics provides the consensus-scored MIR760 profile across patient tissues and cancer cell-line models. MIR760 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, MIR760 is differentially expressed in 5, with the highest sampling consensus in KICH. Additionally, MIR760 RNA expression shows 10,217 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight COAD, KICH, and THYM as cancer lineages where MIR760 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR760 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR760 survival associations across molecular data types. MIR760 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR760 RNA expression–survival associations across cancer types. High MIR760 expression shows unfavorable associations in COAD, ACC, UVM and THCA, but favorable associations in UCS and SKCM. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify COAD as the clearest survival context for MIR760 RNA expression.
This table summarizes MIR760 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for MIR760. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR760 shows lower tumor expression in KICH, THCA, UCEC, LUAD and BRCA and higher tumor expression in LUAD. The KICH box plot shows higher MIR760 RNA expression in normal versus tumor tissue (log2 FC = −0.886, t-test p < 0.001).
This table shows molecular features associated with MIR760 in patient tissues and cancer cell lines. In patient samples, MIR760 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
